Dawnzera (Donidalorsen)

Donidalorsen is a medicine that helps prevent swelling attacks in people with hereditary angioedema (HAE). It is a shot given under the skin. It works by telling the liver to make less of a protein that sets off the swelling.

Brand names:Dawnzera
Medication

What people taking Dawnzera (Donidalorsen) report

Every report comes from a Lived member, sent anonymously.

Have you tried Dawnzera (Donidalorsen) for Hereditary Angioedema?

NameHow it went

About Dawnzera (Donidalorsen)

What It's For

Donidalorsen, sold as Dawnzera, is a prescription injection that helps prevent attacks of hereditary angioedema (HAE) in adults and children 12 and older. HAE is a rare inherited condition that causes repeated episodes of deep swelling in the skin, the gut or the throat. These attacks can be painful and disabling, and when they affect the throat they can be life-threatening. Donidalorsen is a long-term preventive, sometimes called prophylaxis. It is taken on a schedule whether or not symptoms are present, with the goal of making attacks less frequent and less severe. It does not stop an attack that has already started, so people who use it still need an on-demand medicine for breakthrough attacks. It was approved in the US in August 2025 and joins other preventive options for HAE, such as lanadelumab, berotralstat and C1 inhibitor replacement. Its safety and effectiveness have not been established in children younger than 12.

How It Works

In the common forms of HAE, the body lacks enough working C1 inhibitor, a protein which normally keeps a chain of blood proteins in check. Without enough of it, an enzyme called plasma kallikrein becomes overactive and releases bradykinin, a substance that makes small blood vessels leak fluid. That leaking fluid is the swelling of an HAE attack. Donidalorsen works one step earlier in that chain. It is an antisense medicine, a short, man-made strand of genetic material designed to latch onto the instructions the liver uses to make prekallikrein, the inactive starting form of plasma kallikrein. Once those instructions are destroyed, the liver makes less prekallikrein, so there is less raw material available to produce bradykinin. The medicine is built to be taken up mainly by the liver, which is where prekallikrein is made. It does not fix the underlying C1 inhibitor problem, which is why it has to be continued to keep working.

Dosage & Administration

Donidalorsen comes as a single-dose autoinjector containing 80 mg, injected under the skin. The usual schedule is one injection every 4 weeks. An every-8-week schedule is also allowed on the label, but in the main study it prevented fewer attacks, so it is a choice to weigh with the prescriber rather than an automatic convenience. The injection is designed to be given at home by the patient or a caregiver after training. Self-injection goes into the abdomen or upper thigh; the back of the upper arm can be used when someone else gives the shot. Take the autoinjector out of the refrigerator about 30 minutes before use and let it reach room temperature on its own, without heating it. The liquid should be clear and colorless to yellow; do not use it if it looks cloudy, discolored or has particles. If needed, the pen can be kept at room temperature (up to 86°F) in its carton for up to 6 weeks, then discarded if unused. If a dose is missed, give it as soon as you remember, then count the next dose from that new date.

Side Effects

The most common side effect is a reaction where the shot was given: redness, itching, pain, bruising, firmness or a change in skin color. In the main study, about a quarter of people on the every-4-week schedule had one, and all were mild. Colds and other upper respiratory infections, urinary tract infections and stomach discomfort were also reported somewhat more often than with placebo. Blood tests in the studies showed a small average drop in platelets (the blood cells that help clotting) and mild rises in liver enzymes, which generally leveled off. No one in the studies had a dangerously low platelet count or major bleeding from it. Serious allergic reactions, including anaphylaxis, have occurred. Signs include a widespread rash, trouble breathing, chest pain or swelling around the mouth. If these happen, do not give further doses and call 911 or get emergency care right away. Because swelling around the mouth can also be an HAE attack, the safe step is the same either way: treat it as urgent. Anyone who has had a serious allergic reaction to donidalorsen should not use it again.

Interactions & Warnings

No specific drug interactions are listed on the US label, but that reflects limited study rather than proof that none exist. Share a full list of medicines and supplements with the prescriber, especially other HAE treatments. Switching from another preventive, such as lanadelumab, berotralstat or C1 inhibitor, is a planned decision; in an open-label study people switched directly to donidalorsen, but the timing should come from the HAE specialist. There are no human data on use during pregnancy or breastfeeding. In animal studies, the medicine did not harm developing offspring and did not cross the placenta, but animal results cannot settle the question for people. Anyone pregnant, planning pregnancy or breastfeeding should weigh the options with their HAE specialist. Donidalorsen has not been studied in people with moderate or severe kidney disease, which is worth raising before starting.

What to Expect

Donidalorsen starts lowering prekallikrein within the first month, and in the main 24-week study people on the every-4-week schedule had about 81% fewer attacks than people on placebo. About half had no attacks at all from week 4 to week 24, compared with fewer than 1 in 10 on placebo. The every-8-week schedule cut attacks by about 55%. Results vary from person to person, and longer-term open-label data suggest the benefit holds for at least a year with continued use. Because it is a preventive, success looks like fewer, milder attacks and fewer days lost to swelling, not zero risk. Breakthrough attacks can still happen, so keep an on-demand HAE medicine with you and know how to use it. Swelling in the throat, hoarseness, a lump feeling or trouble swallowing or breathing is an emergency even while on prevention: use the on-demand medicine and call 911. Follow-up with the HAE specialist usually involves tracking how often attacks occur, how severe they are and how well the injections are tolerated, and deciding whether the dosing interval fits.

Questions to Ask Your Doctor

  1. 1.How does donidalorsen compare with other preventive options for me in terms of how often I would inject, how well it works and cost?
  2. 2.Should I start on the every-4-week schedule, and would every 8 weeks ever make sense for me?
  3. 3.Which on-demand medicine should I keep with me for breakthrough attacks, and when should I use it?
  4. 4.If I am switching from another preventive, how should we time the change?
  5. 5.Will I need blood tests for platelets or liver enzymes while I take it?

Last reviewed • Oct 2026

Educational content, not medical advice.